IP Library Granted Patent US 10,751,364
Granted Patent B2
US 10,751,364 · App. 16/103,056 · Granted Aug 25, 2020

Nitric oxide topical application apparatus and methods

Inventors: C. Michael Miller (Pleasant Grove, UT); Gordon K. Hill (Sandy, UT); A. John Pate (Provo, UT); David A. Bell (Farmington, UT)
Assignee: SYK TECHNOLOGIES, LLC
A61K33/00A61K9/0014A61K9/122A61K31/19A61K31/194A61K31/375A61P17/00A61K47/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,751,364
App. No.
16/103,056
Granted
Aug 25, 2020
Kind
B2
Abstract

A topical application of nitric oxide may be provided by two separate containers, each containing an active component media to produce nitric oxide when combined. For example, a nitrite component media may be contained in one dispenser and an acidified component media may be contained in another dispenser. Each dispenser may dispense the respective component media as a foam. The resultant foams are combined to initiate the production of nitric oxide and the mixture of foams is applied topically to treat various skin disorders or wounds.

Claims (47)

1. A composition for transdermal absorption of nitric oxide comprising:

a first solution comprising water, at least one nitrite reactant, and a cationic surfactant;

a second solution comprising water, at least one acidic reactant, and the cationic surfactant;

a first foam obtained by aerating the first solution;

a second foam obtained by aerating the second solution; and

a collapsible foam obtained by mixing the first foam and the second foam.

2. The composition of claim 1 , wherein:

the first solution comprises approximately 100 mL of water, 10 g of sodium nitrite, and 1 g of the cationic surfactant; and

the second solution comprises approximately 100 mL of water, 5 g of lactic acid, 6 g of citric acid, and 3 g of the cationic surfactant.

3. The composition of claim 1 , wherein:

the first solution comprises approximately 100 mL of water, 10 g of sodium nitrite, 2 g of sodium bicarbonate, and 1 g of the cationic surfactant; and

the second solution comprises approximately 100 mL of water, 5 g of lactic acid, 8 g of citric acid, and 3 g of the cationic surfactant.

4. The composition of claim 1 , wherein:

the first solution comprises approximately 100 mL of water, 10 g of sodium nitrite, and 2 g of the cationic surfactant; and

the second solution comprises approximately 100 mL of water, 10 g of citric acid, and 6 g of the cationic surfactant.

5. The composition of claim 1 , wherein:

the first solution comprises approximately 100 mL of water, 10 g of sodium nitrite, 2 g of sodium bicarbonate, and 2 g of the cationic surfactant; and

the second solution comprises approximately 100 mL of water, 5 g of ascorbic acid, 8 g of citric acid, and 6 g of the cationic surfactant.

6. The composition of claim 2 , wherein the collapsible foam produces a nitric oxide to nitrogen dioxide ratio averaging between approximately 90% and 120%.

7. The composition of claim 5 , wherein the collapsible foam produces a nitric oxide to nitrogen dioxide ratio averaging between approximately 60% and 70%.

8. The composition of claim 1 , wherein the nitrite reactant is selected from the group consisting of sodium nitrite and potassium nitrite, and the acidic reactant is selected from the group consisting of citric acid, lactic acid, salicylic acid, and phosphoric acid.

9. A composition for treating skin comprising:

a first solution comprising approximately 100 mL of water, 10 g of sodium nitrite, and 2 g of a cationic surfactant; and

a second solution comprising approximately 100 mL of water, 10 g of citric acid, and 6 g of the cationic surfactant;

a first foam obtained by aerating the first solution;

a second foam obtained by aerating the second solution; and

a collapsible foam obtained by mixing the first foam and the second foam.

10. The composition of claim 9 , wherein the first solution further comprises 2 g of sodium bicarbonate.

11. The composition of claim 9 , wherein the collapsible foam produces a nitric oxide to nitrogen dioxide ratio averaging between approximately 90% and 120%.

12. The composition of claim 10 , wherein the collapsible foam produces a nitric oxide to nitrogen dioxide ratio averaging between approximately 60% and 70%.

13. The composition of claim 9 , wherein the first solution further comprises a salt buffer for regulating the reaction rate of nitric oxide production.

14. A collapsible foam composition for transdermal absorption of nitric oxide comprising:

a first solution comprising water, at least one nitrite reactant, and a cationic surfactant;

a second solution comprising water, at least one acidic reactant, and the cationic surfactant;

a first foam obtained by aerating the first solution;

a second foam obtained by aerating the second solution; and

the collapsible foam obtained by mixing the first foam and the second foam, wherein the collapsible foam substantially collapses within approximately five (5) minutes after being placed on a portion of skin of a user.

15. The collapsible foam composition of claim 14 , wherein:

the first solution comprises approximately 100 mL of water, 10 g of sodium nitrite, 2 g of sodium bicarbonate, and 1 g of the cationic surfactant; and

the second solution comprises approximately 100 mL of water, 5 g of lactic acid, 8 g of citric acid, and 3 g of the cationic surfactant.

16. The collapsible foam composition of claim 14 , wherein:

the first solution comprises approximately 100 mL of water, 10 g of sodium nitrite, and 2 g of the cationic surfactant; and

the second solution comprises approximately 100 mL of water, 10 g of citric acid, and 6 g of the cationic surfactant.

17. The collapsible foam composition of claim 14 , wherein the first solution further comprises a salt buffer for regulating the reaction rate of nitric oxide production.

18. The collapsible foam composition of claim 14 , wherein the nitrite reactant is selected from the group consisting of sodium nitrite and potassium nitrite, and the acidic reactant is selected from the group consisting of citric acid, lactic acid, salicylic acid, phosphoric acid, and ascorbic acid.

19. The collapsible foam composition of claim 14 , wherein the collapsible foam produces a nitric oxide to nitrogen dioxide ratio averaging between approximately 90% and 120%.

20. The collapsible foam composition of claim 15 , wherein the collapsible foam produces a nitric oxide to nitrogen dioxide ratio averaging between approximately 60% and 70%.

Assignments (5)
SECURITY INTEREST Recorded Apr 24, 2024
From: NO2020, LLC
To: KNOBBE, MARTENS, OLSON & BEAR, LLP
Reel/Frame 067217/0866 →
SECURITY INTEREST Recorded Apr 24, 2024
From: SYK TECHNOLOGIES LLC
To: KNOBBE, MARTENS, OLSON & BEAR, LLP
Reel/Frame 067217/0917 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 23, 2023
From: SYK TECHNOLOGIES, LLC
To: NOXY HEALTH PRODUCTS, INC.
Reel/Frame 064349/0263 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2022
From: PATE, A. JOHN; HILL, GORDON K.
To: SYK TECHNOLOGIES, LLC
Reel/Frame 059155/0261 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2022
From: BELL, DAVID A.; MILLER, C. MICHAEL
To: SYK TECHNOLOGIES, LLC
Reel/Frame 059155/0671 →
Continuity (5)
Continuation 15415550 · Jan 25, 2017
Provisional Application 62287755 · Jan 27, 2016
Provisional Application 62432744 · Dec 12, 2016
Provisional Application 62438375 · Dec 22, 2016
Related Publication 20190134080A1 · May 9, 2019
Cited By (1)
US 12,252,398